Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids

Simons, 2000, Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol., 1, 31, 10.1038/35036052 Pike, 2003, Lipid rafts: bringing order to chaos. J. Lipid Res., 44, 655, 10.1194/jlr.R200021-JLR200 Wong, 2000, Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc. Natl. Acad. Sci. USA., 97, 8681 Marchesini, 2004, Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol., 82, 27 Perry, 1998, The role of ceramide in cell signaling. Biochim. Biophys. Acta., 1436, 233, 10.1016/S0005-2760(98)00145-3 Ruvolo, 2003, Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res., 47, 383 Kronke, 1999, Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes. Chem. Phys. Lipids., 101, 109 Subbaiah, 1993, Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase. J. Biol. Chem., 268, 20156 Bolin, 1996, Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem., 271, 19152 Subbaiah, 2006, Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate. Biochemistry., 45, 5029 Rye, 1996, The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem., 271, 4243 Koumanov, 1997, Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem. J., 326, 227 Gesquiere, 2002, Role of group IIa and group V secretory phospholipases A2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry., 41, 4911 Klapisz, 2000, Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A(2). J. Lipid Res., 41, 1680 Lobo, 1997, Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase. Biochim. Biophys. Acta., 1349, 122 Arimoto, 1998, Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J. Lipid Res., 39, 143 Subbaiah, 2001, Sphingomyelin: a natural modulator of membrane homeostasis and inflammation. Med. Hypotheses., 57, 135 Chap, 1977, Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim. Biophys. Acta., 467, 146 Kudo, 2002, Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat., 68–69, 3, 10.1016/S0090-6980(02)00020-5 Nevalainen, 2000, Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim. Biophys. Acta., 1488, 83 Tselepis, 2002, Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler. Suppl., 3, 57 Hanasaki, 1999, Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem., 274, 34203 Bezzine, 2000, Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem., 275, 3179 Cho, 2000, Structure, function, and regulation of group V phospholipase A(2). Biochim. Biophys. Acta., 1488, 48 Murakami, 1998, The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem., 273, 14411 Pruzanski, 2005, Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim. Biophys. Acta., 1736, 38 Subbaiah, 2003, Sphingomyelinase D, a novel probe for cellular sphingomyelin: effects on cholesterol homeostasis in human skin fibroblasts. J. Lipid Res., 44, 1574 Subbaiah, 1992, Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim. Biophys. Acta., 1128, 83 Fukasawa, 2000, Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta-cyclodextrin. J. Biol. Chem., 275, 34028 Bligh, 1959, A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911 Subbaiah, 2004, Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans. J. Lipid Res., 45, 2245 Hanasaki, 2002, Potent modification of low density lipoprotein by group X secretory phospholipase A(2) is linked to macrophage foam cell formation. J. Biol. Chem., 277, 29116 Slotte, 1999, Sphingomyelin-cholesterol interactions in biological and model membranes. Chem. Phys. Lipids., 102, 13 Ridgway, 1998, Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization. J. Biol. Chem., 273, 31621 Zha, 1998, Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol., 140, 39 Huang, 1998, Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2. Eur. Biophys. J., 27, 361 Hashizume, 1999, Ceramide enhances susceptibility of membrane phospholipids to phospholipase A(2) through modification of lipid organization in platelet membranes. Biol. Pharm. Bull., 22, 1275 Fanani, 1997, Mutual modulation of sphingomyelinase and phospholipase A2 activities against mixed lipid monolayers by their lipid intermediates and glycosphingolipids. Mol. Membr. Biol., 14, 25 Koumanov, 2002, Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity. Biochem. J., 363, 45 Pettus, 2004, Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem., 279, 11320 Saiga, 2005, Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha. Prostaglandins Other Lipid Mediat., 75, 79 Gulbins, 2003, Raft ceramide in molecular medicine (review). Oncogene., 22, 7070 Balsinde, 1997, Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis. J. Biol. Chem., 272, 20373 Singer, 2002, Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J. Biol. Chem., 277, 48535 Subbaiah, 1989, Molecular species of phosphatidylcholine in familial lecithin-cholesterol acyltransferase deficiency: effect of enzyme supplementation. Biochim. Biophys. Acta., 1003, 145 Ballou, 1996, Ceramide signalling and the immune response. Biochim. Biophys. Acta., 1301, 273 Memon, 1998, Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol., 18, 1257 Ledesma, 1999, Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J., 18, 1761 Lightle, 2003, Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch. Biochem. Biophys., 419, 120 Schissel, 1996, Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest., 98, 1455 Oorni, 1998, Sphingomyelinase induces aggregation and fusion, but phospholipase A(2) only aggregation, of low density lipoprotein (LDL) particles—two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J. Biol. Chem., 273, 29127 Kinnunen, 2002, Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis? Trends Cardiovasc. Med., 12, 37